Bloomberg Law
Health Law & Business News

Supreme Court Suggests It Will Back Access to Abortion Pill

The US Supreme Court signaled it’s likely to preserve full access to a widely used abortion pill as the justices heard arguments in a case carrying major stakes for reproductive rights and potentially this year’s elections.

Abortion Pill Fight Isn’t Over. Foes Look to 1873 Obscenity Law

While the US Supreme Court <-bsp-bb-link state="{"bbDocId":"SAYTF3T1UM0W","_id":"0000018e-7d1f-d509-adee-7ddf07440001","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">appears poised to keep a widely used abortion pill available for now, some conservative justices signaled an interest in considering whether a 151-year-old indecency law should prevent American women from receiving the drug by mail.

Medicare Advantage Insurer Sues HHS Over Rating Calculation

A Medicare Advantage insurer sued the Biden administration claiming that regulators improperly calculated the company’s quality ratings, which if not corrected would terminate the company’s participation in the Medicare Advantage program.

Pharmacy Giants Urge Court to Bar Ohio Opioid Liability Claims

CVS Pharmacy Inc., Walgreens Boots Alliance Inc., and Walmart Inc. told the Ohio Supreme Court Tuesday that the state’s product liability law bars claims that they exacerbated an opioid problem in two Ohio counties.

Medicare Wegovy Coverage Spurs Employer Action on Drug Plans

Medicare coverage of Novo Nordisk A/S’s blockbuster weight-loss drug Wegovy for heart disease is putting even more pressure on employers to cover the pricey drug that some are finding unaffordable.

PRACTITIONER INSIGHTS

View More Insights

Latest Stories

Troubled NJ Hospital Chain Taps Insight to Stabilize Finances

A Michigan company that rescued a bankrupt Chicago hospital has stepped in to run operations at <-bsp-bb-link state="{"bbHref":"bbg://securities/1822065D%20US%20Equity","_id":"0000018e-8366-dd73-a18e-c76785a90000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">CarePoint Health, the long-troubled system across the river from Manhattan.

Bayer-Backed Drug Maker Boundless Bio Raises $100 Million in IPO

<-rte-company state="{"_id":"0000018e-8237-dd73-a18e-c7379ceb0000","_type":"00000160-4b23-d8bd-adfd-4b3348fd0000"}">Boundless Bio Inc., a cancer therapeutics maker that counts <-rte-company state="{"_id":"0000018e-8237-dd73-a18e-c7379ceb0001","_type":"00000160-4b23-d8bd-adfd-4b3348fd0000"}">Bayer AG among its largest investors, raised $100 million in a US initial public offering after pricing shares at the midpoint of a marketed range.

Valsartan Adulteration Lawsuit Sees Most Claims Head to Trial

Labels identifying drugs as valsartan constituted express warranties about the medications’ safety, but whether manufacturers breached the warranty depends on disputed facts, a federal judge said ahead of a bellwether trial in litigation alleging generic blood pressure medications were contaminated by a carcinogenic substance.

Podiatrist, Supplier Sue HHS Over Tissue Product Coverage Denial

A Michigan-based podiatry practice and its medical supplier are suing the Biden administration, alleging the arbitrary denial of coverage of human cell and tissue-based products for patients with osteoarthritis, tendonitis, and other orthopedic conditions.

Beyond Abortion: The Fight Over Fetal Personhood Is Here

When do legal rights begin, at birth or before that? This video looks at the fetal personhood movement, and what it could mean for the future of abortion. We explore its history and the constitutional argument underpinning it.

From Across Bloomberg Law

Business & Practice Environment & Energy Report Environmental, Social & Governance (ESG) The United States Law Week
  • Business & Practice
  • Environment & Energy Report
  • Environmental, Social & Governance (ESG)
  • The United States Law Week

Covid Vaccine & Personal Data: Does HIPAA Still Matter?